Is This Biotech Stock After Groundbreaking Approval?
A breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
Treat index level as a practical tool to guide trades, enabling more consistent setups and disciplined execution across markets.
20,888 articlesA breakthrough approval can move a biotech stock in dramatic ways. This guide breaks down how to assess the upside, m...
Celebrity wellness stories grab headlines, but behind the flash are real costs and tricky choices. This article break...
Howard Lindzon’s work with StockTwits and Social Leverage reshapes how we think about investing in communities. This ...
Frontier is expanding capacity in key markets after Spirit exits, betting on demand and scale. The move highlights a ...
Susquehanna lifts Cloudflare to a $200 price target as the AI-first reset takes shape. The stock sits near $196 after...
SVB Capital, the bank's roughly $10 billion venture arm, is being shopped as regulators unwind SVB assets. Buyers are...
The United States and Europe are pursuing different routes to regulate AI, and the early market impact is clear—from ...
Investors are weighing the latest earnings from D-Wave Quantum. While losses persisted, revenue beat expectations in ...
As tariffs and a stronger dollar shape markets, IDV’s 4.7% yield just proved its income stream can endure, even as qu...
Doximity is due to report Q4 results after the close, with analysts keyed to FY2027 guidance and margin trajectory as...
Three Reddit-favored speculative bets face pivotal catalysts as spring gains fade. Archer Aviation, Rigetti Computing...
Nonprofit leaders report a surge in demand for services as federal funding tightens under the current administration,...